Skip to main content
. 2020 Dec;81(6):902–910. doi: 10.1016/j.jinf.2020.10.030

Table 2.

Complications of typhoid fever, by United Nations region, 1965–2018.

Complicationsa Africa
Americas
Asia
Oceania
Totalb
n / N (%) n / N (%) n / N (%) n / N (%) n / N (%)
Abdominal
Intestinal perforation 37 / 486 (7.6) 4 / 217 (1.8) 34 / 4,622 (0.7) 5 / 739 (0.7) 80 / 6,064 (1.3)
Gastrointestinal hemorrhage 11 / 320 (3.4) 0 / 0 87 / 2,809 (3.1) 21 / 739 (2.8) 119 / 3,868 (3.1)
Hepatitis 10 / 157 (6.4) 1 / 9 (11.1) 104 / 2,389 (4.4) 17 / 739 (2.3) 132 / 3,294 (4.0)
Cholecystitis 1 / 55 (1.8) 0 / 0 10 / 913 (1.1) 0 / 365 (0.0) 11 / 1,333 (0.8)
Cardiovascular
Asymptomatic electrocardiographic changes ND ND ND ND ND
Myocarditis 2 / 191 (1.0) 0 / 0 30 / 1,979 (1.5) 1 / 365 (0.3) 33 / 2,535 (1.3)
Shock 0 / 14 (0.0) 0 / 0 59 / 3,580 (1.6) 17 / 365 (4.7) 76 / 3,959 (1.9)
Neuropsychiatric
Encephalopathy 0 / 0 0 / 0 98 / 2,460 (4.0) 4 / 365 (1.1) 102 / 2,825 (3.6)
Delirium 34 / 277 (12.3) 0 / 0 650 / 2,027 (32.1) 21 / 344 (5.8) 705 / 2,648 (26.6)
Psychotic states 2 / 50 (4.0) 2 / 217 (0.9) 28 / 1,438 (1.9) 0 / 0 32 / 1,705 (1.9)
Meningitis 6 / 347 (1.7) 1 / 9 (11.1) 13 / 1,625 (0.8) 0 / 0 20 / 1,981 (1.0)
Impairment of coordination ND ND ND ND ND
Respiratory
Bronchitis 0 / 0 0 / 0 32 / 407 (7.9) 0 / 0 32 / 407 (7.9)
Pneumonia 4 / 191 (2.1) 7 / 226 (3.1) 43 / 1,416 (3.0) 18 / 374 (4.8) 72 / 2,207 (3.3)
Hematologic
Anemia 132 / 311 (42.4) 52 / 226 (23.0) 683 / 3,516 (19.4) 150 / 703 (21.3) 1,017 / 4,756 (21.4)
Disseminated intravascular coagulation 0 / 0 0 / 0 98 / 660 (14.8) 1 / 374 (0.3) 99 / 1,034 (9.6)
Other
Focal abscess 1 / 47 (2.1) 0 / 0 0 / 0 0 / 0 1 / 47 (2.1)
Pharyngitis ND ND ND ND ND
Miscarriage 0 / 0 0 / 0 1 / 6 (16.7) 0 / 0 1 / 6 (16.7)
Relapse 6 / 171 (3.5) 2 / 129 (1.6) 71 / 2,166 (3.2) 0 / 0 79 / 2,466 (3.2)
Chronic carriage ND ND ND ND ND
Seizure or convulsionsc 14 / 125 (11.2) 0 / 0 94 / 4,224 (2.2) 0 / 0 108 / 4,349 (2.5)
Total complications 260 / 689 (37.7) 69 / 226 (30.5) 2,135 / 8,681 (24.6) 255 / 739 (34.5) 2,719 / 10,335 (26.3)
Total Complications as described by study 116 / 348 (33.3) 24 / 327 (7.3) 401 / 3,028 (13.2) 128 / 739 (17.3) 669 / 4,442 (15.1)
*a

Complications from Parry et al. Table 11

ND = No data. Data could not be abstracted as these complications were not described in any of the included articles.

**b

Europe not shown due to the single study from Europe including participants diagnosed with stool and urine cultures, therefore it was not possible to distinguish complications among those diagnosed by culture of a normally sterile site. 101.

^cComplication not listed by Parry et al